Skip to main content
TipRanks
Go Ultimate75% OFF

Bruce Sargent Insider Profile

4 Followers

Bruce Sargent, former Sr VP, Drug Discovery at Albany Molecular Research, holds 55.39K shares in Albany Molecular Research (Ticker: AMRI).

Bruce Sargent's Trading History

AMRI
Albany Molecular Research
Jun 04, 2013―Uninformative Sell―$1.20M
AMRI
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 04, 2013Uninformative Sell$0.001,704$0.00―
May 23, 2013Informative Sell$82.28K7,500$10.97-43.80%
Mar 20, 2013Informative Sell$5.11K514$9.94-101.30%
Mar 13, 2013Informative Sell$64.31K6,154$10.45-59.90%
Feb 26, 2013Informative Sell$8.05K984$8.18-95.30%

You May Also Like

Bruce Sargent insider profile FAQ

What is the percentage of profitable transactions made by Bruce Sargent?
The percentage of profitable transactions made by Bruce Sargent is 22%.
What is the average return per transaction made by Bruce Sargent?
The average return per transaction made by Bruce Sargent is -119.70%.
What stocks does Bruce Sargent hold?
Bruce Sargent holds: AMRI stocks.
What was Bruce Sargent's most profitable transaction?
Bruce Sargent’s most profitable transaction was an Informative Sell of AMRI stock on May 12, 2011. The return on the trade was 39.20%.
What is Bruce Sargent's role in Albany Molecular Research?
Bruce Sargent's role in Albany Molecular Research is Sr VP, Drug Discovery.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.